Additionally, TUDCA inhibits the endoplasmic reticulum stress response, therefore mitigates insulin resistance (Kars et al., 2010; Vettorazzi et al., 2017), as well as protects cells from inflammatory damage and lowers the systematic inflammation (Alhasani et al., 2020), while the inflammation indicated as elevated CRP, TNF-α, and IL-6 also can drive the dysfunction of pancreatic β-cells and increase the insulin resistance in patients with T2D (Donath and Shoelson, 2011). Here, CRP is linked to type 2 diabetes mellitus.